Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14108154 | 0.91 | ALDH1A1 (0.47) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL5096454 | 0.87 | ALDH1A1 (0.46) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL5445684 | 0.85 | MAPK1 (0.45) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL5433238 | 0.85 | ALDH1A1 (0.45) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL5443361 | 0.85 | MAPK1 (0.45) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL14489594 | 0.85 | MAPK1 (0.45) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL14503823 | 0.83 | ALDH1A1 (0.45) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL5090573 | 0.82 | MAPK1 (0.43) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL974955 | 0.81 | MAPK1 (0.42) | ALDH1A1TSHRKMT2APOLBMAPK1 | |
| SCHEMBL976753 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TSHRKMT2APOLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080076785-A1 | 7-Aminomethyl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds And Their Use For Controlling Pathogenic Fungi | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-27 | — | — | US | disclosed |
| EP-1797097-A1 | 7-AMINOMETHYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006034848-A1 | 7-AMINOMETHYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND THEIR USE FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080076785-A1 | 7-Aminomethyl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds And Their Use For Controlling Pathogenic Fungi | H1-0, NAT1, DPM1 | ALDH1A1 2830/4885TSHR 3431/4885KMT2A 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.